Estazolam Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Estazolam Tablets contain an amount of Estazolam equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of estazolam (C16H11CIN4)
2 IDENTIFICATION
The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Buffer: 2.8 g/L of potassium phosphate, monobasic in water. Adjust to a pH of 6.5 with 1 N NaOH.
Mobile phase: Acetonitrile, methanol, and Buffer (10:35:55)
Standard solution: 0.02 mg/mL of USP Estazolam RS in Mobile phase
Sample solution: 0.02 mg/mL of Estazolam in Mobile phase, from NLT 20 finely powdered Tablets. Nore-Sonicate for 5 min. Pass a portion through a suitable filter with no glass prefilter.]
Chromatographic system
(See Chromatography (621), System Suitability)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm x 15-cm; 3-um packing L11
Flow rate: 1 mL/min
Injection size: 25 μL
Run time: 2.7 times the retention time of the estazolam peak
System suitability
Sample: Standard solution
Suitability requirements
Talling factor: NMT 2.0%
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of C16H11CIN4 in the portion of Tablets taken:
Result = (rU/(rS) × (CS /CU) x 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Estazolam RS in the Standard solution (mg/mL)
CU = concentration of Estazolam in the Sample solution (mg/mL)
Acceptance criteria: 90.0%-110.0%
4 PERFORMANCE TESTS
DISSOLUTION (711)
Medium: Water, 900 ml, deaerated
Apparatus 2: 50 rpm
Time: 30 min
Buffer and Mobile phase: Proceed as directed in the Assay.
Standard stock solution: 0.1 mg/mL of USP Estazolam RS in methanol
Standard solution: Dilute the Standard stock solution with Medium to obtain a final concentration of about (L/1000) mg/mL, where L is the Tablet label claim in mg.
Sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-um pore size, discarding the first few ml.
Chromatographic system
(See Chromatogranby (621). System Suitability.)
Proceed as directed in the Assay, except for the injection size and run time.
Injection size: 100 µL
Run time: 1.6 times the retention time of estazolam
System suitability: Proceed as directed in the Assay
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of estazolam dissolved:
Result = (rU/(rS) × (CS /L) x 100
rU = peak response of estazolam from the Sample solution
rS = peak response of estazolam from the Standard solution
CS = concentration of USP Estazolam RS in the Standard solution (mg/mL)
L = Tablet label claim (mg)
V = volume of Medium (mL), 900
Tolerances: NLT 80% (Q) of the labeled amount of estazolam is dissolved.
UNIFORMITY OF DOSAGE UNITS (905): Meet the requirements
5 IMPURITIES
ORGANIC IMPURITIES
PROCEDURE
Buffer, Mobile phase, Standard solution, and Sample solution: Proceed as directed in the Assay
Chromatographic system
(See Chromatography (621). System Suitability)
Proceed as directed in the Assay, except for the injection size and run time.
Injection size: 25 µL. for the Standard solution and 50 µl for the Sample solution
Run time: 4 times the retention time of estazolam
System suitability: Proceed as directed in the Assay.
Analysis
Sample: Sample solution
Calculate the percentage of each impurity in the portion of Tablets taken:
Result = (ru/rs) x 100
ru = peak response of each individual impurity from the Sample solution
rs = sum of the responses of all peaks from the Sample solution
Acceptance criteria
Any individual unspecified degradation product: NMT 0.5%
Total impurities: NMT 1.0%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight, light-resistant containers. Store at controlled room temperature.

